BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33093445)

  • 21. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.
    Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
    Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
    Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
    Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J
    BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.
    Kwon T; Bak Y; Park YH; Jang GB; Nam JS; Yoo JE; Park YN; Bak IS; Kim JM; Yoon DY; Yu DY
    Stem Cells; 2016 May; 34(5):1188-97. PubMed ID: 26866938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
    Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
    Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant adeno-associated virus expressing a p53-derived apoptotic peptide (37AA) inhibits HCC cells growth in vitro and in vivo.
    Zhang H; Wang Y; Bai Y; Shao Y; Bai J; Ma Z; Liu Q; Wu S
    Oncotarget; 2017 Mar; 8(10):16801-16810. PubMed ID: 28187431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.
    Xiao Z; Li CH; Chan SL; Xu F; Feng L; Wang Y; Jiang JD; Sung JJ; Cheng CH; Chen Y
    Cancer Res; 2014 Nov; 74(21):6236-47. PubMed ID: 25217526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
    Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
    Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
    Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
    Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.